Structure and function of human 17beta-hydroxysteroid dehydrogenases.
17Beta-hydroxysteroid dehydrogenases (17beta-HSDs) catalyze the NAD(P)(H) dependent oxidoreduction at C17 oxo/beta-hydroxyl groups of androgen and estrogen hormones. This reversible reaction constitutes an important pre-receptor control mechanism for nuclear receptor ligands, since the conversion "switches" between the 17beta-OH receptor ligands and their inactive 17-oxo metabolites. At present, 14 mammalian 17beta-HSDs are described, of which at least 11 exist within the human genome, encoded by different genes. The enzymes differ in their expression pattern, nucleotide cofactor preference, steroid substrate specificity and subcellular localization, and thus constitute a complex system ensuring cell-specific adaptation and regulation of sex steroid hormone levels. Broad and overlapping substrate specificities with enzymes involved in lipid metabolism suggest interactions of several 17beta-HSDs with other metabolic pathways. Several 17beta-HSDs enzymes constitute promising drug targets, of particular importance in cancer, metabolic diseases, neurodegeneration and possibly immunity.
Lukacik
Petra
P
Structural Genomics Consortium, University of Oxford, Oxford OX3 7LD, United Kingdom. petra.lukacik@sgc.ox.ac.uk
Kavanagh
Kathryn L
KL
Oppermann
Udo
U
D015067:17-Hydroxysteroid Dehydrogenases / Q000737:chemistry* / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D011487:Protein Conformation; D013379:Substrate Specificity
D015067:17-Hydroxysteroid Dehydrogenases